Browsing Tag
neuroinflammation
6 posts
Why neuroinflammation and systemic inflammation are becoming central targets in traumatic brain injury research
Why are neuroinflammation and systemic inflammation becoming major targets in traumatic brain injury research? Explore the industry shift now.
Why regulators are closely watching BIOX-101 in spontaneous intracerebral hemorrhage
Why are regulators closely watching BIOX-101 in hemorrhagic stroke? Explore how Bioxodes is targeting accelerated approval pathways.
Why targeting ERK and NF-κB pathways may change Parkinson’s disease drug development
Discover how BioVie Inc. is targeting ERK and NF-κB pathways in Parkinson’s disease and what Phase 2 data could mean. Read the full analysis.
Why industry observers are watching Tenvie Therapeutics’ TNV262 biomarker readout in 2026
Tenvie Therapeutics’ TNV262 readout in 2026 could reshape obesity and cardiometabolic drug development. Read why markets are watching closely.
Tiziana Life Sciences strengthens intranasal foralumab development with Renaissance Lakewood partnership
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA), a clinical-stage biotechnology company focused on immunomodulation therapies, has announced a strategic…
InMed Pharmaceuticals’ INM-901 shows breakthrough potential in Alzheimer’s disease treatment
In a significant development in Alzheimer’s disease research, InMed Pharmaceuticals Inc., a biotechnology company specialising in the development…